Abstract Background Glioblastoma (GBM) is the most common brain tumor with the worst prognosis. Temozolomide is the only first-line drug for GBM. Unfortunately. the resistance issue is a classic problem. https://www.hindigyanvishv.com/hot-save-Herbstonne-Black-Eyed-Susan-big-savings/